Saudiarabien - engelska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

atnahs pharma uk limited, united kingdom - granisetron - tablet - 1 mg

Saudiarabien - engelska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

atnahs pharma uk limited, united kingdom - granisetron - injection - 1 mg/ml

Saudiarabien - engelska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

atnahs pharma uk limited, united kingdom - ibandronic acid - tablet - 150 mg

Saudiarabien - engelska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

atnahs pharma uk limited, united kingdom - diazepam - solution for injection - 5 mg/ml

Saudiarabien - engelska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

atnahs pharma uk limited, united kingdom - granisetron - injection - 1 mg/ml

Europeiska unionen - engelska - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronic acid - hypercalcemia; breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases - bondronat is indicated for:prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases;treatment of tumour-induced hypercalcaemia with or without metastases.

Europeiska unionen - engelska - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronic acid - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis in postmenopausal women at increased risk of fracture (see section 5.1). a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium hydroxide; sodium chloride; hydrochloric acid - adults:,kytril (tablets and injection) is indicated for use in adults for:,the prevention of nausea and vomiting induced by cytotoxic chemotherapy; the prevention of nausea and vomiting induced by radiotherapy. kytril (injection) is also indicated for use in the treatment of nausea and vomiting induced by cytotoxic chemotherapy; and prevention and treatment of post-operative nausea and vomiting.,paediatric:,kytril injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

atnahs pharma uk ltd - naproxen - gastro-resistant tablet - 500mg

Irland - engelska - HPRA (Health Products Regulatory Authority)

atnahs pharma netherlands b.v. - granisetron hydrochloride - solution for injection - 1 milligram(s)/millilitre - serotonin (5ht3) antagonists; granisetron